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ABSTRACT
Clinicians are using transcranial magnetic stimulation (TMS) as a
noninvasive tool to treat depression; however, standards for determining the
motor threshold (MT), which often determines the final location of the TMS coil
and the intensity of simulation for the depression treatment, are not clear. This
study compared the observation of movement (OM) method and
electromyography (EMG) method of determining motor threshold in a group of
experienced TMS administrators and nurses with no previous MT knowledge.
We hypothesized that between methods and groups the MT estimates would
vary by < 50/0 of stimulator output and the ideal motor scalp location between
methods would vary by < 1 cm.
TMS administrators determined the MT twice with each MT method on
one subject in a randomly assigned order. The subject and administrators were
blind to TMS machine output. After determining the ideal motor scalp location,
each TMS administrator then used the 5 cm rule to locate the optimal prefrontal
treatment site. The scalp position over the anatomical hand knob and the EEG
F3 position were located for comparison.
There was no significant difference in the motor threshold estimates
between the OM and EMG MT methods (t(14)=0.659, p=0.521). The mean EMG
and OM MT estimates were (61.80/0 (sd=7.25) and 63.1 % (sd=9.05). Therewas
no effect for the interaction between estimation method and experience level
(F(1,13)=0.036, p=0.851) on MT estimates. The mean distance between the MT
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sites and the hand knob was 21.25 (sd=8.98), while the mean distance between
the treatment sites and F3 was 36.16 (sd=12.15).
The wide range of MT estimates and motor scalp locations reveals several
problems with the MT procedure for the OM and EMG methods. The standard
EMG or OM methods along with the 5 cm rule may position the coil posterior and
medial to the intended treatment location.
This study shows that nurses with minimal MT training can determine the
MT and localize the treatment site as effectively as experienced TMS operators.
Information obtained from this study can be used to establish MT protocols and
to institute training programs that test each participant's ability to master the TMS
procedure.
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INTRODUCTION

Transcranial magnetic stimulation (TMS) is a new noninvasive technology
experiencing exponential growth as a treatment for depression and nurses have
an opportunity to shape its treatment and training protocols. TMS involves strong
oscillating magnetic pulses applied to the scalp with a metal coil that are strong
enough to cause neuronal depolarization. In October of 2008, the United States
Food and Drug Administration (FDA) cleared a TMS device as a treatment for
unipolar depression (Tillman, 2008). TMS is for prescription use and must be
administered by a medically trained person. The nurses' medical knowledge and
ability to manage potential side effects caused by TMS makes them well suited to
deliver TMS treatments. Prescribing clinicians and nurses need standards for
determining dose and treatment location to ensure treatment uniformity across
TMS clinics.
In the way clinicians currently apply TMS, motor threshold determination is
a fundamental element of a successful TMS treatment for depression. MT is an
estimate of cortical excitability that varies within individuals, and which
determines the final location of the coil and the intensity of simulation for the
depression treatment (Rossini et aI., 1999). Traditionally, researchers have
determined MT by applying TMS over the motor cortex and recording motor
evoked potentials (MEP) of the relaxed target muscle with an electromyography

(EMG) device (Barker, Jalinous, & Freeston, 1985). After finding MT, the
depression researcher moves the TMS coil 5 em forward in order to stimulate the
prefrontal cortex (George et aI., 1995). More recently, the observation of
movement (OM) method of MT determination has gained popularity with
clinicians treating depression with TMS. The widespread adoption of the OM
method over the EMG assisted method for MT determination has occurred with
only four small studies directly comparing the two methods (8alslev, Braet,
McAllister, & Miall, 2007; Conforto, Z'Graggen, Kohl, Rosier, & Kaelin-Lang,
2004; Hanajima et aI., 2007; Pridmore, Fernandes Filho, Nahas, Liberatos, &
George, 1998).
Standardizing the MT procedure is important to compare treatment
outcomes across TMS studies and to deliver TMS at the proper location within
the published safety guidelines (Wassermann, 1998). This translational research
study compared the intensity and location of OM MTs to EMG MTs. We tested
results from studies conducted previously which suggest that the range of MT
estimates between EMG and OM methods will be within 5% of total machine
output, and that the MT scalp locations would not vary widely, being within a 1
em area. We examined the location and distance achieved with the 5 em rule
applied after the OM MT and EMG MT. Investigators then compared the MT and
treatment locations found by the newly trained nurses to those found by
experienced TMS administrators. Also compared were MT scalp locations to
hand knob, and treatment locations to F3.
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This document consists of three manuscripts. The first manuscript is a
literature review of methods and techniques of MT determination. The second
manuscript compares the OM and EMG MT methods in a group of experienced
TMS administrators and nurses with no previous TMS experience. The third
manuscript is an introduction to TMS in clinical settings for nurses with limited
TMS knowledge. This document will provide nurses with a better understanding
of TMS and the MT methods. Additional training will be required before a
clinician should administer TMS.
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MANUSCRIPT 1- REVIEW OF THE LITERATURE
This manuscript has been published in the Journal of the American Psychiatric
Nurses Association: Anderson, B. S. and George, M.S. (2009). A Review of

Studies Comparing Methods for Determining Transcranial Magnetic Stimulation
(TMS) Motor Threshold - Observation of Movement or EMG-Assisted.
INTRODUCTION:
Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive
technique cleared by the United States Food and Drug Administration (FDA) in
October of 2008 for patients with unipolar depression who have failed to respond
to at least one antidepressant medication in their current depressive episode.
Clinicians apply rTMS by placing an insulated metal coil on the patient's scalp
and passing brief oscillating electric current through the coil, thus generating
magnetic fields that pass unimpeded through the hair, skin, and bone to cause
neural depolarization. Patients remain awake and alert during the rTMS
procedure. The most common rTMS side effects are discomfort at the site of
stimulation and headache. Unlike electroconvulsive therapy, rTMS does not
require a seizure for therapeutic benefit. However, rTMS has caused
unintentional seizures on rare occasions (Conca, Konig, & Hausmann, 2000;
Nowak, Hoffmann, Connemann, & Schonfeldt-Lecuona, 2006; Tharayil,
Gangadhar, Thirthalli, & Anand, 2005; Wassermann, 1998).
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The motor threshold (MT) is an estimate of cortical excitability that
quantifies the dose of rTMS; its location provides a reference for the treatment
site. MT estimates vary between individuals but are relatively stable within
subjects over time (Rossini et aI., 1999). Psychiatric nurses and other clinicians
using rTMS as a treatment for depression estimate the MT with the observation
of movement (OM) method or the electromyography (EMG) assisted method to
establish treatment dose.
Traditionally, neurophysiologists have estimated MT by applying the TMS
coil over the motor cortex in a grid like pattern and recording motor evoked
potentials (MEP) of the relaxed or resting target muscle of the abductor pollicis
brevis (APB) or the first dorsal interosseus (FOI) with an EMG (Barker et aI.,
1985). The resting motor threshold (rMT) target muscles are not active and are
not opposing gravity while active motor threshold (aMT) muscles are typically
engaged to a specific measurement of force, measured with a strain gauge. For
the purposes of this manuscript, all MT refers to resting MT unless otherwise
noted. More recently, some researchers, particularly those administering rTMS
in clinical research trials, have used an alternative method of determining MT that
does not utilize an EMG machine called the observation of movement or
visualization method. Instead of positive MEPs, the OM method substitutes
observed movements of the thumb, wrist, or fingers. In different variants of the
OM method, clinicians may limit positive movements to the target muscle or may
accept movements from the whole hand.
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It is unclear whether the OM method produces MTs similar to the EMGassisted method. Perhaps the first to introduce the idea of watching for a visible
contraction of the APB muscle when determining the motor threshold were
investigators of a study working with obsessive-compulsive patients who had
concerns about germs and hand skin contact (Greenberg, Ziemann, Harmon,
Murphy, & Wassermann, 1998). Their study did not attempt to compare the
EMG-assisted and OM methods, nor did it suggest that the OM method should
replace the EMG-assisted method. Nevertheless, many researchers began
using the less expensive and expedient OM method.
Clinicians express the power required for reliable motor responses as a
percent of total machine output and dose treatment relative to this number. This
manner of expressing the dose of rTMS does not quantify the magnetic field
strength of the TMS coil. Although it references the dose to the excitability level
of the patient, it is not a measurable quantifiable unit such as the induced
magnetic field. Consequently, the same magnetic intensity may not be delivered
·to different patients even if prescribed the same dose of MT (e.g. 100 %

)

because

of their differing MTs.
Several motor threshold estimating techniques are combined with EMG or
OM to establish the MT estimate (Table 1) (Awiszus, 2003; Herwig et aI., 2002;
Mills & Nithi, 1997; Mishory et aI., 2004; Pridmore et aI., 1998; Rossini et aI.,
1994; Rothwell et aI., 1999). Early MT guidelines by Rossini et al. suggested that
TMS machine output should be slowly increased until MEP amplitudes of 100 IJV
in 50% of 10 consecutive stimuli are recorded. Other researchers have
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condensed this MT recommendation to allow for MEP amplitudes of 50 f.,JV and
three positive responses out of six stimuli (Herwig et aI., 2002). A different
method of determining MT, which calls for an upper and lower threshold, was
presented by Mills and Nithi. They defined the upper threshold as 10
consecutive positive responses with MEPs of 20 f.,JV. Conversely, the lower
threshold is 10 negative responses. The average of the upper and lower
thresholds yields the overall MT for an individual.
The maximum-likelihood strategy (MLS) is a fourth approach of estimating
the MT (Awiszus, 2003; Mishory et aI., 2004). The MLS method uses a
computerized algorithm that dictates the next intensity of machine output based
on negative and positive responses (50-100 f.,JV) to stimuli. The predictive power
and efficiency of the maximum-likelihood strategy reduces the number of total
pulses needed and may increase accuracy (Awiszus, 2003; Awiszus, Feistner,
Urbach, & Bostock, 1999; Mishory et aI., 2004). The previously mentioned
physiological techniques rely on the assistance of an EMG, though many
clinicians simply apply these formulas to the OM method.
Another concern for rTMS clinicians is finding the motor threshold "hot
spot" or optimal location where the "threshold is the lowest and the onset latency
is shortest"

(Rossini et aI., 1994). In a recent study, researchers examined five

localization techniques (center of gravity, International 10-20
electroencephalography (EEG) system, fMRl, group fMRl, and MEP of maximal
amplitude) and concluded that stereotactically guided coil placement has the
greatest precision (Sparing, Buelte, Meister, Paus, & Fink, 2008). However,
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precise MRI guided positioning is controversial, finding differences with a
behavioral (e.g. movement) approach. That is, one can base the coil position
guided by brain structural anatomy (the hand knob for thumb movement) as seer
on MRI, or the functional region that is activated with thumb movement as
determined by blood-oxygen-Ievel dependent functional MRI, or by simply
behaviorally searching for the optimum scalp location where the TMS coil best
produces thumb movement. These different approaches to placement, as
indicated in the Denslow study, do not result in the same scalp position for the
coil, even for something as simple as thumb movement (Denslow, Bohning,
Bohning, Lomarev, & George, 2005; Denslow, Lomarev, Bohning, Mu, & George,
2004; Denslow, Lomarev, George, & Bohning, 2005). Moreover, most research
labs and clinics performing rTMS as a treatment for depression do not have
expensive MRI and frameless stereotactic equipment available and simply
substitute the less costly International 10-20 EEG system or MEP of maximal
amplitude method to find the optimal MT location and final treatment position.
Depression researchers are still using a variety of rTMS treatment
techniques with mixed outcomes. Recent randomized controlled trials of rTMS
as a treatment for depression are compared in Table 2. These studies have at
least 15 subjects in each group and were published from January 2007 to July
2008 (Fitzgerald et aI., 2008; Herwig et aI., 2007; Jorge, Moser, Acion, &
Robinson, 2008; Loo, Mitchell, McFarquhar, Malhi, & Sachdev, 2007; Mogg et
aI., 2007; Q'Reardon et aI., 2007b). All the depression studies reviewed in table
2 target the prefrontal cortex (PFC) as the optimal treatment location. Most of
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these studies used the MT dependent 5 cm rule to locate the prefrontal cortex
position. Other studies relied on the International 10-20 EEG system, which is
not influenced by the location of the MT. All studies used the MT value to
calculate the TMS dose, yet the stimulation parameters were not uniform across
studies. It is apparent that researchers using rTMS as a treatment for depression
rely on MT to determine the dose of TMS and sometimes use the position
established for the MT to determine the treatment location.
Standardizing the motor threshold procedure is important to compare
treatment outcomes across rTMS studies and to deliver rTMS within the
published safety guidelines (Wassermann, 1998). This paper critically reviews
the evidence comparing the OM method to the EMG-assisted method for
determining motor threshold.
METHODS:
To uncover literature that compares the OM method to the EMG-assisted
method for determining MT, the authors collected published articles written in
English from January 1995 through April 2008 by systematically searching the
electronic database Medline. Authors combined the keyword terms: transcranial
magnetic stimulation, motor threshold, motor evoked potentials and movement to
narrow the focus of the search. Fifty-five citations were found. Authors then
reviewed the abstracts of all articles for relevance to this paper's objective. In
addition to electronic searches, the authors searched references in TMS articles
and consulted TMS experts by posting to the list server of the International
Society for Transcranial Stimulation. Appropriate articles are summarized in
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Table 3 using an evidence grading system (Greer, Mosser, Logan, & Halaas,
2000).
RESULTS:
Though fifty-five articles were identified, only four articles provided a direct
comparison of the two methods under review (Table 3) (Balslev et aI., 2007;
Conforto et aI., 2004; Hanajima et aI., 2007; Pridmore et aI., 1998). The first and
most cited study comparing the two methods of determining MT was by Pridmore
and colleagues in 1998. This study involved six right-handed male researchers
between the ages of 29-50 years. Researchers used a Dantec MagPro (Dantec
Medical, Medtronic Inc, Minneapolis, MN) with a figure-8 coil to deliver
stimulation. This TMS machine, unlike more modern systems, has a relatively
crude dial for changing the intensity and delivers TMS in 5% output gradations.
Pridmore et al. (1998) started with supramaximal stimulation over the site
of greatest sensitivity then decreased machine output by approximately 2%. The
technique used to find the optimal motor location was not presented. The EMGassisted MT used the lowest intenSity setting which produced MEP amplitude of
at least 50 IJV in at least five out of ten stimulations in the APB muscle; while the
OM method substituted any movement of the whole hand for MEPs. Each
subject had two sessions in a random order. They concluded that the OM
method of determining MT was roughly similar to the EMG-assisted method
when using a TMS machine with limited dial output gradations and allowing any
movement in the hand or wrist to count as a positive response. That is, the
difference between the two MT determining techniques was less than the 50/0
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fixed difference in output built into the machine making the two techniques yield
'near-equivalent' results on that machine.
This study by Pridmore et al. (1998) laid the groundwork for the use of the
OM method in some clinical TMS treatment settings. In spite of the paucity of
research, many research labs and clinicians began using the OM method based
solely on this limited information even when they were using machines with 10/0
output gradations. Pridmore et al.'s sample of six men is small and
underpowered, capable of only finding very large effects, especially considering
the variable nature of the motor threshold (Wasserman, 2002). Because TMS
delivered over the motor cortex at low frequencies of 1 Hz can alter the MT,
Rothwell et al. (1999) suggested separating pulses by more than three seconds
when determining the MT. Pridmore et al. did not explicitly state the interval
between TMS pulses, but rather provided the non-specific rate of <1 Hz. It is
important to realize that the EMG-assisted method Pridmore et al. used relied on
MEPs only from the APB muscle, but then counted any movement of the
contralateral hand during the OM method. Pridmore et al. found that five out of
six subjects had a lower MT value with whole hand OM than with EMG-assisted.
However, no subject showed a difference of more than 40/0 of machine output.
Despite the limitations of this study, Pridmore et al. set the stage for the use of
the OM method for determining motor threshold in clinical settings, thus
potentially reducing the time and expense of the procedure and allowing for
treatment in settings other than neurophysiology laboratories.
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The second published study that directly compared the EMG-assisted and
OM methods for determining motor threshold was by Conforto et at (2004).
They proposed the term movement threshold be assigned to the OM method and
motor threshold refer to "thresholds measured with MEP evaluation". Conforto et
al. expanded on previous work and stimulated in a block-randomized fashion
over APB and a fixed scalp position in 16 healthy subjects. The nasion-inion line
and interauralline cross at the vertex of the head and the fixed position site was
marked on a swim cap 5 cm left of the vertex on the interaural line. Stimulation
for locating the optimal APB site started at 70% machine output and decreased
by 5% increments while meticulously searching in half-centimeter increments
until no MEPs greater than 1OO~V were recorded at APB, FDI, and bicep brachii
(BB). Then the motor threshold was determined by increasing the machine
output until 5 out of 10 trials produced MEPs of at least

50~V.

The movement

threshold used the same five out of ten rule but counted any movement of the
fingers or wrist just as Pridmore et al. (1998) described.
Conforto et al. (2004) more than doubled the sample size of the previous
study and provided an explicit explanation of how to find the optimal site to
stimulate over APB. However, the method used by Conforto et al. to determine
movement threshold relied on EMG to find the optimal location and ensure the
muscle was at rest before stimulation occurred. The standard OM method as
described by Pridmore and colleagues in 1998 includes movements of the whole
hand and does not have a system that monitors voluntary muscle contractions or
motor tensing that might alter the motor threshold. Conforto et al. used an MEP
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monitoring system that identified one subject with voluntary muscle contractions.
They removed this subject's data from the final analysis due to his contracted
muscles during stimulation. Conforto et al. did not examine the critical
components of finding the optimal spot to stimulate the APB using the OM
method. This limits the usefulness of their findings in TMS clinical settings that
lack EMG equipment.
Conforto et al. (2004) found that, overall, resting motor thresholds (EMGassisted method) were lower than movement thresholds (whole hand OM
method), while Pridmore et al. (1998) concluded the opposite in 5 out of the 6
subjects studied. Conforto et al. did not provide the raw thresholds for each
subject; rather, they gave the group means for movement and motor thresholds,
which were within 2% of machine output. While this mean difference is small, it
appears that one subject had a 12% machine output difference between the two
methods. The outlier with the largest difference in the percent of machine output
may be unique or represent a problem with the OM method. As the group mean
difference between the EMG-assisted and OM methods was only 2%, the overall
conclusion by Pridmore et al. was upheld.
In 2007 both Hanajima et al. and Balslev et al. reported that the EMGassisted method overall produced lower resting motor thresholds than did the
OM method, confirming findings by Conforto et al. (2004). However, there were
differences in the methods of these studies. The two earlier studies targeted the
relaxed APB muscle for the EMG method and accepted any movement of the
whole hand for the OM method. Alternatively, both Hanajima et al. and Balslev
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et al. limited positive responses to twitches or appropriate MEP amplitudes of the
relaxed FDI muscle. Movements of muscles other than the FDI muscle did not
constitute a positive response. In a small sample of 10 subjects, Hanajima et al.
compared five different methods of determining motor threshold in both relaxed
and active muscles. Balslev et al. compared resting MTs of four subjects from a
larger study examining the effect coil position has on MT. The mean MT
difference between the EMG-assisted and OM method was 6% and 2% machine
output respectively for Hanajima et al. and Balslev et al. Like their predecessors,
Hanajima et al. and Balslev et al. found the optimal motor location for each
subject and gave all stimulation over this area. All four of the reviewed MT
studies used magnetic stimulators with figure eight flat coils.
DISCUSSION:
Despite the relatively small evidence to support the assertion that the OM
method is similar to the EMG-assisted method for determining motor threshold in
clinical settings, many clinicians are using the faster, less complicated OM
method. The pivotal FDA trial for rTMS in depression used the OM method and
clinical settings treating depression with rTMS have adopted it (O'Reardon et aI.,
2007). However, it is important to remember that the rTMS safety tables were
published using EMG determined MTs and do not account for possible
differences with other methods (Wassermann, 1998).
The four studies that have directly compared the various motor threshold
methods have yielded somewhat opposing findings. The total number of
subjects in all four of these studies is 35. In addition, none of these studies
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addressed how to use the OM method to find the optimal site to stimulate the
target muscle. In depression studies, the APB is often the target and the rTMS
treatment is delivered 5 cm anterior of this spot (George et aI., 1995). The
incorrect identification of the APB location may preclude the rTMS treatment from
occurring over the prefrontal cortex as designed. Pridmore et al. (1998)
considered any movements of the hand or wrist as acceptable positive
responses to stimuli, and Conforto et al. (2004) repeated this liberal strategy.
The EMG-assisted method focuses on recording MEPs from a more defined area
than the entire hand or wrist and thus provides a more accurate location of the
optimal spot to stimulate. If the APB is the target, then clinicians should consider
only thumb movement as a positive response when determining optimal MT
location.
The EMG-assisted method ensures delivery of stimulation to a relaxed
muscle, which is critical as contracted muscles can produce larger MEPs than
relaxed muscles that receive the same intensity of stimulation (Oi Lazzaro et aI.,
1998; Hanajima et aI., 2007). Contracted muscles may yield erroneous positive
responses, which may be problematic for new computerized algorithms that rely
on fewer stimuli to achieve the final MT, rendering them more influenced by false
positive or negative responses.
Function-based techniques like the EMG-assisted and OM methods,
where the scalp location is referenced to the motor APB location, do not reliably
position the coil over the target area (Herwig, Pad berg, Unger, Spitzer, &
Schonfeldt-Lecuona,2001). The International 10-20 EEG system or image
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guided positioning are other techniques to consider when positioning the TMS
coil. Perhaps this would reduce TMS administrator error introduced when
placing the coil for treatment.
Calculating the TMS dose based on MT has long been a practice to
ensure the safety of the patient (Wassermann, 1998). Functional responses over
the motor cortex may not correlate to a safe and effective treatment over different
areas of the brain. More research is needed to determine the optimal and safe
dose of TMS pver each target area. At present, there is a lack of consensus on
how best to perform the motor threshold procedure. Clearer guidelines for
determining MT, which are paramount to a safe and likely effective treatment,
would help the field. As the safety data concerning TMS were established with
the EMG and the available evidence supporting the OM method is sparse;
additional studies are needed to directly compare the two approaches. For
research and clinical application where the stimulation parameters are at or near
the safety guidelines, or involve scalp locations or patient populations at risk of
seizure, the EMG-assisted method is a more conservative approach.
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Table 1. Techniques for estimating the motor threshold.
Citation

Response
Criteria

Rossini et
aL, 2004

500/0 of 1020
consecutive
stimuli
500/0 of 1020
consecutive
stimuli
10
consecutive
stimuli.
Average of
upper MT
and lower
MT
5 out of 10

Rothwell et
aL, 1999

Mills &
Nithi, 1997

Pridmore et
aI., 1998

Herwig et
aI., 2002
Awiszus,
2003
Mishory et
aL,2004

EMG
amplitude or
OM method
EMG-100 ~V

Interstimulus
Interval
n/a

Starting
Stimulation
Intensity
Subthreshold

EMG-50

~V

3 seconds

Suprathreshold

EMG-20

~V

3 seconds

Subthreshold

<1 Hz

Suprath reshold

2 seconds

n/a

3.5 seconds

Subthreshold

3 seconds

Suprathreshold

3 seconds

Suprathreshold

3 out of 6

EMG-50 ~V
orOM
method thumb, wrist,
or finger.
EMG-50 ~V

Algorithm

EMG-50

3 out of 6

OM methodany finger
movement.

~V

Algorithm
EMG-100

~V
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Table 2. Randomized controlled trials of rTMS as a treatment for depression (January 2007 - July 2008).
Citation
Herwig et
aI., 2007

Design/ Subjects
Blinded, randomized
controlled trial of 127
subjects with unipolar
or bipolar disorder.
In addition to active or
sham rTMS, all
subjects received
venlafaxine or
mirtazapine.

Loo et aI.,
2007

Blinded, randomized
controlled trial of 36
subjects with unipolar
depression.
Subjects (n=36) were
medication free or
stable on an
antidepressant.

Coil Placement technique
Device: Magstim Rapid with
figure-eight coil.

Parameters
Sham or active stimulation.
Tx location: left OLPFC
Frequency: 10Hz
On time: 2 sec
Off time: 8 sec
Intensity: 110 % rMT
# of pulses/day: 2,000
# of pulses/study: 30,000

rMT method: EMG-assisted
method.
Tx location: Over F3 using the
International 10-20 system.

Sham stimulation was given
above the left temporal
muscle with an active coil
angled at 45 degrees.
Sham or active stimulation.

Device: Magstim Super Rapid
with a 70 mm figure-eight coil.

Tx location: left PFC
Frequency: 10Hz
On time: 5 sec
Off time: 25 sec
Intensity: 110% rMT
# of pulses/day: 3,000
# of pulses/study: 30,000

rMT method: EMG-assisted
method with the APB as the
target.
Tx location: The 5 cm rule was
applied to reach the left PFC.

Two rTMS sessions a day for
2 weeks.
An inactive coil was used for
Sham sessions.
--,-
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Outcome/Results
Response was defined as a
decrease in total score of 500/0
on at least two scales (HRSD21, MAORS, or BOI).
At 3 weeks:
Active group (n=52) response
rate 31 %1.
Sham group (n=53) response
rate 31 %.

Response was defined as a
decrease in the MAORS total
score of at least 50% from
baseline.
Active group response rate
33.30/0.
Sham group response rate
16.6%.

Citation
Mogg et
al.,2007

Design/ Subjects
Blinded, randomized
controlled trial of 59
subjects with unipolar
depression.
Antidepressants
remained stable.

Parameters
Sham or active stimulation.

Coil Placement technique
Device: Magstim Super Rapid
with figure-eight coil.

Tx location: left PFC
Frequency: 10Hz
On time: 5 sec
Off time: 55 sec
Intensity: 110% rMT
# of pulses/day: 1,000
# of pulses/study: 10,000

rMT method: OM method with the
APB muscle as the target and
lowest intensity in 3 out of 6 trials.
Tx location: The 5 cm rule was
applied to reach the right PFC.

Sham stimulation given with a
sham coil that looks identical
to the real coil, but does not
introduce a magnetic field to
the brain.

O'Reardon
etal., 2007

Blinded, randomized
controlled trial for
unipolar depression.
Active group n=155
Sham group n=146

Tx location: left DLPFC
Frequency: 10Hz
On time: 4 sec
Off time: 26 sec
Intensity: 120% rMT
# of pulses/day: 3,000
# of pulses/study: 60,00090,000

rMT Method: OM method with the
assistance of a mathematical
algorithm.
Tx location: The 5 cm rule was
applied to reach the left PFC.

Sham stimulation given with a
sham coil that looks identical
to the real coil, but does not
introduce a magnetic field to
the brain.
'---
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Remission defined as 17-item
HRSD < 9.
Active group (n=28) response
rate 32%.
Sham group (n=29) response
rate 10%.
Active group (n=28) remission
rate 25%.
Sham group (n=29) remission
rate 100/0.

Device: Neuronetics Model 2100
Therapy System.

Sham or active stimulation.

Outcome/Results
Response was defined as a
decrease in the HRSD-17 total
score of at least 50% from
baseline.

Response was defined as a
decrease in the MADRS total
score of at least 50% from
baseline.
After 4 weeks of rTMS:
Active group response rate
18.10/0.
Sham group response rate
11.0%.
After 6 weeks of rTMS:
Active group response rate
23.9%.
Sham group response rate
12.3%.

I

!

Citation
Fitzgerald
etal.,2008

Design/ Subjects
60 subjects stable on
medication with
unipolar or bipolar
disorder received
unblinded 1 Hz
stimulation.
In addition to this
treatment, Group A
received pretreatment
with 6 Hz stimulation
and Group B received
sham in a blinded
fashion.

Parameters
All subject received active
stimulation over the right
PFC.
Frequency: 1 Hz
On time: 15 min
Intensity: 110 % rMT
# of pulses/day: 900
# of pulses/study: 9,00018,000

Coil Placement technique
Device: Medtronic Magpro 30 with
70-mm, figure-eight coil.
rMT method: OM method with the
APB muscle as the target and
lowest intensity in 5 out of 10
trials.
Tx location: The 5 cm rule was
applied to reach the right PFC.

Group A: Pretreatment
Tx location: right PFC
Frequency: 6 Hz
On time: 5 sec
Off time: 25 sec
Intensity: 90% rMT
# of pu Ises/day: 600
# of pulses/study: 6,00012,000

Outcome/Results
Response was defined as a
decrease in the MADRS total
score of at least 500/0 from
baseline.

Active-priming + slow TMS
response rate= 33%)
Sham-priming + slow TMS
response rate= 14 %

Group B: Pretreatment
Sham stimulation was give
with an active coil angled at
45 degrees.

Jorge et
aI., 2008

Blinded, randomized
controlled trial for
vascular depression.
92 antidepressant free
subjects in experiment
#1 were given sham
TMS or 12,000 pulses
and in experiment #2
were given sham or __

Experiment #1
Sham or active stimulation.

Device: Magstim Super Rapid
Stimulator; 70-mm, figure 8shaped butterfly coils.

Tx location: left DLPFC
Frequency: 10Hz
On time: 6 sec
Off time: 60 sec
Intensity: 1100/0 MT
# of pulses/day: 1,200
# gfpulses/study: 12,000

rMT Methods: EMG-assisted
method with the FDI muscle as
the target. MLS-PEST and
positive MEP in 5 out of 10 trials.
Tx location: MRI guided over
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Response was defined as a
decrease in the HRSD-17 total
score of at least 50% from
baseline.

Experiment #1.
Active group: response rate
33.3%

Citation

Design/ Subjects
18,000 pulses.

Coil Placement technique
Brodmann area 46.

Parameters
Experiment #2
Sham or active stimulation.

Experiment #2.
Active group: response rate
39.4%
Sham group: response rate
6.9%

Tx location: left DLPFC
Frequency: 10Hz
On time: 6 sec
Off time: 60 sec
Intensity: 110% rMT
# of pulses/day: 1,200-2,400
# of pulses/study: 18,000
--
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Outcome/Results
Sham group: response rate
6.7%.

I

Table 3. Evidence comparing the EMG-assisted and OM methods for determining motor threshold (January 1995
- April 2008).
Citation

Design type

Pridmore The OM method was
compared to the EMGaI.,
1998
assisted method for
determining MT in the
relaxed APB muscle.

~t

Population
Primary Outcome
Authors' Conclusions
Measures/Results
Studied/Sa
mple Size
6 rightIThe mean difference
IThe OM method and the EMGhanded
between EMG assisted assisted method are similar;
men aged method and OM method however, 5 out of 6 subjects
~as 1.7% of total
29-50
had motor thresholds that were
lower when using the OM
years.
stimulator output.
method.

Random order.
'The subjects and TMS
operator were unblinded
~o the condition.
Conforto iThe OM method was
et aI.,
compared to the EMG
2004
assisted method for
determining MT in the
relaxed APB muscle.

Limitations

Class /
Quality

The optimum spot for
stimulation was located with the
assistance of EMG for both
methods.

A, -

Observed thumb, fingers or
rwrist movement was considered
~ positive responds for the OM
method.

Small sample size.
IThe mean difference
The difference between the OM iThe optimum spot for
8 righthanded
between EMG-assisted method and the EMG-assisted stimulation was located with the
men and 8 method and OM method method were small; however, assistance of EMG for both
women
13 out of 14 subjects had motor methods.
:was 1.9 % of total
~hresholds that were higher
aged 21- stimulator output.
29 years.
rwhen using the OM method.
Observed fingers or wrist
Block randomization.
movement was considered a
positive responds for the OM
A blinded investigator was
method.
used to observe
movement in the right
hand.
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A, -

Authors' Conclusions
Population
Primary Outcome
Measures/Results
Studied/Sa
mple Size
Mean threshold values Motor thresholds were higher
Hanajima Unblinded comparison of 7 rightrwhen using the OM method.
handed
RMT mov- 55.8%
5 different methods of
let aI.,
determining MT in relaxed men and 3 AMT mov- 43.3%
~007
RMT mov1- 51.6%
and active muscles (FDI). Iwomen,
AMT mov1- 36.50/0
~ged 30RMT raw- 49.8%
53 years.
MTmov- visible finger
AMTraw - 35.1 %
movements (8 out 16
AMTraw1 - 33.4%
~rials)
RMT rec - 47.0%
MTmov1- visible finger
AMTrec - 29.4%
movements (1 out 16
Design type

Citation

Limitations

Class /
Quality

Irhe optimum spot for
stimulation was located with the
assistance of EMG for both
methods.

C, -

Small sample size.

~rials)

The mean difference
MTraw- EMG assisted
between EMG-assisted
(MEPs greater than 50uv
method (55.8) and OM
in half of the trials).
method (49.8) was 6%
MTrawr EMG assisted
of total stimulator
(MEPs greater than
output.
100uv in half of the trials).
MTrec - intensity 1.3 times
larges than mean
background activity.
The OM method and the EMG~ subjects The OM method
Balslevet Irhe primary study
produced MTs that were assisted method are highly
aI., 2007 evaluates coil orientation
correlated.
higher on average by
on MT, in a blinded
20/0 of total stimulator
~ashion, using the OM
output.
method. In a subgroup of
~his population, the EMGassisted method was
applied to the FDI muscle.
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Irhe optimum spot for
stimulation was not located with
each method.
Small sample size.

A, -
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MANUSCRIPT II - METHODS AND RESULTS
To be submitted to the journal Brain Stimulation; A Comparison of the
Observation of Movement Method and Electromyography Method of Determining
Motor Threshold in Transcranial 'Magnetic Stimulation.
INTRODUCTION:
Transcranial magnetic stimulation (TMS) is a noninvasive technique in
which clinicians' pass electricity through a metal coil producing brief oscillating
magnetic pulses capable of depolarizing neurons directly below the coil's face.
Activation of motor neurons allows clinicians to functionally map brain areas and
estimate cortical excitability. In addition, TMS has several neurological and
psychiatric treatment indications with the most promising being depression.
Based on a large clinical trial, the United States Food and Drug Administration
(FDA) approved a TMS device in the fall of 2008 for the treatment of unipolar
depression in patients who have not experienced a response to one
antidepressant medication in their current depressive episode (O'Reardon et al.,
2007a).
Currently, the most frequently used location for treating depression is over
the border of Brodmann areas 9 and 46 within the dorsolateral prefrontal cortex
(DLPFC). The most common method used to localize the DLPFC involves first
identifying the motor threshold of the abductor pollicis brevis (APB) muscle and
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then moving the TMS coil 5 em anterior in a parasagital plain to the optimal
treatment site. The dose or intensity of TMS treatments are based on excitability
of the APB muscle (George et aI., 1995; George et aI., 1996). The motor
threshold is the anchor for nearly all TMS depression studies and clinical TMS for
depression (Anderson & George, 2009).
Mapping APB MT site is the first step of a TMS treatment. Mapping is
based on the center of gravity (COG) of motor evoked potentials (MEP)
(Wassermann, McShane, Hallett, & Cohen, 1992). This technique requires that
the clinician record MEPs from several points on a grid over the motor cortex
then calculate the mean MEP amplitude. Clinicians using TMS to treat
depression shortened the COG process by simply moving the coil over the motor
cortex until they identify a strong MEP. This location is marked and called the
motor threshold (MT) optimal location. With the coil over the scalp in what is
assumed to be the location to best measure the MT, the lowest intensity or power
that reliably depolarizes neurons and causes muscle activation is found and
expressed as a percent of total machine output (Rossini et aI., 1994). Since
there is no simple functional measure of DLPFC excitability, clinicians extrapolate
the estimate of motor excitability for the TMS treatment (Kozel et al., 2000;
McConnell et aI., 2001; Nahas et aI., 2001). Clinicians most often give
depression treatments over the DLPFC at 100-120% of the MT estimate.
Early TMS researchers used an electromyography (EMG) to record MEP
of the contralateral APB muscle. This traditional EMG method was the standard
for depression trials until an alternative was introduced in a small 1997 OCD trial
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(Greenberg et aI., 1997). This newer MT method did not use an EMG device;
rather, it simply replaced recorded positive MEPs with observed movements
(OM) of the hand or fingers. Many depression researchers and TMS
manufacturers adopted the OM method as standard practice for TMS delivery.
Several small studies have compared the intensity of the EMG and OM
methods of determining MT. None have considered the importance of coil
placement (Anderson & George, 2009). In these studies, clinicians identified the
optimal MT site with the EMG method and then used the alternative method over
the same so called motor hot spot. Researchers assumed that the MT location is
the same for each MT method. In addition, imaging studies suggest that the 5
cm rule applied to the MT falls short of the intended treatment location, thus
optimizing only 32% of TMS treatments (Herbsman et aI., 2009; Herwig et aI.,
2001; Herwig, Satrapi, & Schonfeldt-Lecuona, 2003). In current clinical practice,
most TMS clinicians assume that the OM method is similar to the EMG method,
the latter thought to determine the MT accurately in both location and intensity.
Basic knowledge of TMS and brain anatomy is required to reduce the risk
of seizure and to deliver an effective treatment. TMS training is not standardized
and instructors have few guidelines to follow when teaching the next generation
of TMS administrators. A medically trained person in seizure management
should deliver TMS treatment. Many clinics rely on nurses to fulfill this role
(Belmaker et aI., 2003; Pridmore, Khan, Rosa, & George, 2003). Most nurses
are new to TMS and will need standardized training to ensure all patients receive
appropriate stimulation. Our study involved training nurses on how to determine
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the MT scalp location and intensity using the OM and EMG methods. In addition,
nurses learned how to locate the DLPFC using the 5 cm rule.
In this study, we compared the intensity and location of OM MTs to EMG
MTs. We tested results from studies conducted previously which suggest that
the range of MT estimates between EMG and OM methods will be within 50/0 of
total machine output and that the MT scalp locations would not vary widely, being
within a 1 cm area (Conforto et aI., 2004; Pridmore et aI., 1998; Sparing et aI.,
2008). We examined the location and distance achieved with the 5 cm rule
applied after the OM MT and EMG MT. Investigators then compared the MTs
and treatment locations found by the nurses to those found by experienced TMS
administrators. Also compared were MT scalp locations to hand knob, and
treatment locations to F3.

METHODS AND MATERIALS:
Fifteen TMS administrators and one healthy 35-year-old participated in the
study. The subject and all TMS administrators signed the MUSC Institutional
Review Board approved informed consent. Each TMS administrator preformed
the MT procedure four consecutive times on the subject. There were two study
groups, one comprised of ten experienced TMS administrators, the other
comprised of five nurses with no previous MT knowledge. The nurses received a
one to two hour didactic session on MT determination followed by one hour of
practice on the subject. The nurses' MT sessions were not on the same day as
their practice session. The non-nurses had at least one year of experience with
TMS and did not receive extra training for this study.
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The study investigator acquired a structural brain image of the subject
using a 3T MRI scanner (Intera, Philips Medical System, The Netherlands) with
fiducial markers on the scalp at vertex and 5 cm anterior, posterior, left and right
of vertex. The investigator imported the images into a frameless stereotaxy
system called Brainsight™ (Rogue Research Inc., Montreal, Quebec, Canada).
Then, he co-registered the images to Brainsight™ using left and right tragus,
nasion, tip of nose, and five fiducial markers. Finally, the investigator identified
the center of the TMS coil with the system's calibration block.
The subject, with the help of the investigator, placed a Lycra® swim cap
over the scalp. The TMS administrators positioned themselves in such a way
that they could not view the Brainsight™ program running in real time or the TMS
machine output. With help from the investigator, the subject sat in a chair placing
his chin in a chin rest and his head against a support. The Dantec Cantata™
(Copenhagen, Denmark) recorded MEP's of the relaxed abductor pollicis brevis
(APB). Study personnel placed the Ag-AgCI surface EMG electrode over the
belly of the target muscle and the reference on the palmar side of the proximal
phalange. (See figure 1)
Figure 1. EMG electrode placement for APB.
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not find the EMG motor hot spot within 1 cm of the OM motor hot spot for both
MT sessions. Even within method, the distance between the first and second
EMG MT sites and first and second OM MT sites was greater than 1 cm for eight
and six TMS administrators. None of the TMS administrators kept all four MT
sites to within 1 cm of one another. The wide distribution of optimal MT sites
identified by the TMS administrators is alarming since most TMS depression
studies rely on this location to anchor the TMS treatment.
Figure 2. All motor thresholds and treatment sites.

Key:
Black = MT by experienced administrator.
Blue =MT by nurse.
Yellow =Treatment site by experienced administrator.
Red =Treatment site by nurse.
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demonstrated over one hundred years ago (D'Arsonval, 1896). In the early
1980's, Barker and colleagues modernized the TMS device and stimulated the
motor cortex of the human brain with time-varying magnetic fields, causing visible
twitching and recordable muscle action potentials in the contralateral fingers
(Barker et aI., 1985). TMS was a vast improvement over direct brain electrical
stimulation for investigating brain function and excitability, since TMS is mostly
painless, easily administered, and can be focused on a specific area of the brain
without exposing brain tissue (Barker, Freeston, Jalinous, & Jarratt, 1987; Merton
& Morton, 1980).
In the early 1990's, researchers studied the effects that TMS applied over
the dorsolateral prefrontal cortex (DLPFC) had on the symptoms of depression
(George et aI., 1995). Since then, scores of small TMS studies have tested
various TMS parameters on depressed subjects. From these small TMS studies,
several meta-analyses of TMS literature concluded that TMS had antidepressant
properties (Burt, LisanbYJ & Sackeim, 2002; F. A. Kozel & George, 2002; Martin
et aI., 2002; McNamara, Ray, Arthurs, & Boniface, 2001). In 2007, the largest
TMS study for unipolar depression (n = 301) showed that four weeks of TMS had
greater antidepressant effects than sham TMS in a less ill subgroup of their study
population (O'Reardon et aI., 2007b). Depression is by far the most studied
disorder and the only treatment indication approved by the FDA. Meanwhile,
TMS studies in schizophrenia, post-traumatic stress disorder, obsessivecompulsive disorder, personality disorders, panic disorder, tinnitus, Parkinson's
disease, and Tourette's syndrome are ongoing (see www.clinicaltrials.gov). In

58

addition, the analgesic properties of TMS are under investigation (Borckardt et

aI., 2006).
TMS DEVICE:
The capacitors and coil are the two main parts of a TMS machine.
Energy is stored in the capacitors, and then discharged though the coil as
needed. The capacitors dimensions vary between manufacturers, but most are
the size of a medium suitcase and plug into a standard 110 volt power outlet.
The TMS coil is a figure-eight design that contains metal windings inside a hard
plastic insulating cover that prevents electric shock from current passing through
the coil. Other coil designs include a singular circular configuration that produces
a less focused magnetic field than the figure-eight coil; a deep cone design that
reaches deeper brain areas than the tradition figure-eight coil; and the iron-core
coils that are compact and heavy. The magnetic field produced by the TMS
device is about the same as an MRI machine (1-3 tesla); however, the magnetic
field dissipates rapidly from the TMS coil's face and the magnetic field is
exceedingly brief (only milliseconds).
Depending on the efficiency of the coil, and how intense and frequent the
TMS coil is discharging over time, the electric current passing through the coil
can generate enough heat in the coil to burn the scalp, if internal coil temperature
monitoring did not shut down the machine at a pre-set thermal limit. Most TMS
coils have an apparatus that cools the TMS coil to allow higher doses. For
example, loud and cumbersome blower systems use ambient or cold air to help
dissipate heat from the TMS coil. Fluid cooled coils are efficient at removing heat
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from the coil, but are more challenging to manufacture and not in widespread
use. Some TMS coils, especially the solid core coils, relay on radiant heat loss,
but this method may not keep coils cool at higher therapeutic intensities.
The TMS treatment procedure consists of locating the motor hot spot,
estimating the motor threshold intensity, locating the treatment site, and
delivering stimulation at the optimal rate and duration to maximize outcomes.
The motor threshold (MT) refers to the intensity required to depolarize motor
neurons, which causes movement in contralateral muscles and provides an
estimate of cortical excitability. The motor hot spot is the optimal scalp location
for eliciting muscle movement. The intensity of a TMS treatment is typically

1200/0 of the motor threshold estimate and the TMS coil is positioned 5 cm
anterior of the optimal MT site. The MT determination is an essential element of
TMS treatments and requires skill and practice.
Several companies manufacture TMS devices for mapping brain function
with single pulse stimulation, but the NeuroStar TMS Therapy System
(Neuronetics, Inc., Philadelphia, Pennsylvania) is the only TMS device cleared by
the FDA for treating unipolar depression. The use of any other TMS device for
the treatment of depression is off label.

LOCALIZATION OF THE MOTOR THREHOLD:
Stimulating over the brain's motor cortex causes movement in
contralateral muscles. The muscles of the hand are the most convenient
muscles to find and require the least amount of machine power to activate. The
abductor pollicis brevis (APB) or thumb muscle is the preferred target for
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estimating cortical excitability and is roughly 5 cm lateral of vertex (Cz) toward
the tragus of the ear on the interaural line. Clinicians can use the center of
gravity (COG) technique or an abbreviated COG technique to locate the optimal
site on the scalp to stimulate the APB MT. The COG involves stimulating at 1 cm
interval in a grid pattern over the motor cortex and recording motor evoked
potentials (MEP) with surface electromyography (EMG) electrodes. The optimal
MT location or hot spot is the scalp site with the weighted average of the highest
MEP with the lowest intensity. The COG technique is time consuming and
requires considerable EMG knowledge. Most TMS clinicians treating depression
have shortened the COG process by simply moving the coil over the motor
cortex until finding strong MEPs or thumb movements.
To find the MT hot spot using the abbreviated COG locating technique, the
patient sits in a comfortable chair with head support. The clinician attaches the
EMG electrodes to the patient's right hand. The patient's hand, fingers, and
thumb should be relaxed and not opposing gravity during the MT procedure. To
ensure the patients hand is at rest, an EMG can monitor the patient's hand and
provide audio and visual feedback when muscle activity occurs.
The MT starting position is 5 cm lateral of the vertex along the interaural
line on the left side of the head. The starting position (5 cm lateral of CZ) is the
center point of a 5 cm grid over the motor cortex. The patient may wear a swim
cap with a grid drawn on the cap to help track the coil's position. The clinician
places the center of the TMS coil over the starting point and gives 1 pulse every
3-5 seconds at an intensity of 300/0 machine output. Then, the clinician moves
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the coil in 1 cm increments over the grid giving one pulse at each point,
monitoring for positive responses from each magnetic pulse. A positive response
is a MEP of 50uV or observed movement of the thumb when an EMG is
unavailable. If no positive responses result, the intensity increases by 100/0 of
machine output and the procedure repeated. When a positive response is noted,
the intensity decreases by 5% and each point on the grid rechecked. The
clinician makes minor intensity adjustments (2-3%) until positive responses are
reliable. When the clinician finds the optimal MT location with confidence, they
record the site by outlining the coil on the scalp with an indelible pen or by using
a measuring apparatus provided by some TMS manufacturers. This site is the
MT hot spot.
The patient's hand is at rest during the MT; however, an active thumb or
the "hitchhiker thumb" can help quickly locate the MT hot spot since it requires
less machine output to activate contracted muscles. The clinician must switch to
a resting MT hunt once hitchhiker thumb movements help narrow the search.
Knowing the motor homunculus will also help the clinician find the MT hot spot
faster. For example, the hot spot for the thumb is just medial of the lips and
lateral of the little finger (Nakamura et aI., 1998).
There are several alternative techniques to find the MT hot spot including
the hand knob, fMRI, and use of anatomical scalp measures. Briefly, the hand
knob is a unique brain structure identified on an MRI that contains the MT hot
spot. With a functional MRI, the patient moves his or her thumb while the MRI
records blood flow. The center of activation identified by the fMRI is the MT hot
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spot. Both of these methods are expensive due to the cost of an MRI. Further,
both methods require the use of a frameless stereotactic system to relate brain
coordinates to a scalp location and TMS coil placement. The third alternative
technique uses a simple flexible measuring tape to find a standard MT location at
approximately 5 cm lateral of vertex. Clinical practitioners do not commonly use
these alternative MT locating techniques.
MOTOR THRESHOLD ESTIMATE:
The motor threshold estimate is the lowest intensity that consistently elicits
positive motor responses. Clinicians may use the EMG MT method and consider
an MEP amplitude of 50 J,JV as a positive response or utilize the observation of
movement (OM) MT method and count movement of the thumb as a positive
response in resting muscles. The use of the OM method is controversial and the
EMG method is more conservative.
Five positive responses out of 10 stimuli has been the standard criteria for
consistent positive responses; however, new computer algorithms have replaced
the 5 out 10 rule. Maximum-likelihood algorithms dictate the next intenSity of
machine output based on negative and positive muscle responses and predicts
the MT with just a few pulses. TMS manufactures may provide an algorithm
program with their equipment or clinicians may use a free algorithm program
found at www.clinicalresearcher.org.
To perform the MT estimate, the clinician places the TMS coil over the MT
hot spot and starts stimulation at 300/0 machine output. The clinician may choose
to start at 10% machine output lower than the rough MT estimate known from the
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MT localization procedure. This will speed up the MT process. A positive or
negative muscle response to the magnetic pulse is recorded in the computer
algorithm. The program dictates the intensity of the next pulse. The clinician
should wait 3-5 seconds before given the next pulse so that the brain can
recover, thus preventing false positive or negative responses.
There are several alternative methods of estimating the MT. Rossini et al.
suggests slowly increasing intensity until MEP amplitudes of 100 IJV in 50 0/0 of 10
consecutive stimuli are recorded, while Rothwell et al. suggest starting with supra
threshold and decreasing intensity until the MT is found (Rossini et al.! 1994;
Rothwell et aI., 1999). Mills and Nithis average the upper threshold and lower
threshold to yield the overall MT for an individual. They consider a positive
response as having an MEPs of 20 IJV and the upper threshold as 10
consecutive positive responses and the lower threshold as 10 consecutive
negative responses (Mills & Nithi, 1997). These methods require an

EM~,

though many clinicians substitute thumb movements for positive EMG response
when applying these formulas. A detailed review of MT methods is outside the
scope of this paper, but available by Anderson and George, 2009.

LOCALIZATION OF TREATMENT SITE:
The TMS treatment site over the DLPFC is commonly localized 5 cm
anterior in a parasagittal plane from the scalp location of the MT hot spot.
However, this 5 cm rule may be short of the DLPFC in some patients and
clinician may need to increase the distance to 6 cm (Herbsman et aI., 2009;
Herwig et aI., 2001; Herwig et aI., 2003). The simplicity of using a flexible ruler to
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measure 5 cm from the motor hot spot has attracted the majority of TMS
clinicians. None the less, another low cost method of localizing the DLPFC
known as the F3 method is gaining popularity. F3 is a scalp location over the
DLPFC named by the International 10-20 system for electroencephalography
(EEG) electrode placement (Jasper, 1958). The F3 method uses the nasionionin line, interaural line, and several other head measurements to find the MT
treatment site. MRI guided is a third method of localizing the treatment site, but it
may be too expensive for clinical use.

TREATMENT PARAMETERS:
TMS treatment parameters consist of the coils location, Hz or pulses per
second, on time, off time, intensity, and total number of pulses per session. The
right DLPFC is the preferred location for 1 Hz (one pulse per second) TMS for
depression. This right sided slow stimulation may help the symptoms of
depression and anxiety, but it has not received as much research as has left
sided stimulation. The FDA labeling calls for fast (10Hz) TMS applied to the left
DLPFC. Fast TMS is stimulation given at greater than 1 Hz. It is uncommon to
give fast stimulation on the right side or slow stimulation on the left.
The on time for TMS, known as a train, is 4-5 seconds in duration. There
must be a short rest period known as off time for 10-30 seconds between trains.
The off time allows the brain to rest and recover from the stimulation. The
intensity is the power output of the TMS device and is expressed as a percent of
the motor threshold. For example, if the prescribed intensity is 1200/0 of MT and
the patient's MT is 62% of total machine output, the treatment intensity is 78% of
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total machine output (1.20 X 65 = 78). Therefore, the percent of machine output
is unique to every TMS device.
The total number of pulses per session is usually around 3000 in one
session. Some clinicians administer two sessions in one day with a short break
in between to maximize the treatment day, although one session per day is the
norm. Each TMS session takes about 30-40 minutes to complete. An acute
TMS treatment for depression is one session per day for 5 days a week. A
common TMS treatment regiment for depression is left DLPFC at 10Hz, 4
seconds on, 26 seconds off, 3000 total pulse for 4 weeks. It is likely that
clinicians will increase the total number of pulses and shorten the off time as
more safety information becomes available. Treatment parameters should stay
within current safety tables (Wassermann, 1998).

SAFETY:
TMS is a safe and efficient treatment for depression, but can produce
unwanted side effects. Although rare, seizure is the most notable side effect
related to TMS (Lao, McFarquhar, & Mitchell, 2008). To reduce the risk of
seizure, patients with known seizure disorders or disorders that increase
intracranial pressure are not treated. Clinicians cautiously treat patient taking
medications that lower the seizure threshold, such as stimulants, tricyclic
antidepressants, and bupropion. TMS guidelines by Wassermann et al. (1998)
give known parameters that reduce the risk of seizure.
Patients with cochlear implant, aneurysm clips, brain electrodes, or
ferromagnetic material in their head or neck may not have TMS. Patients with
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most types of dental products can have TMS. Stroke and head trauma are
contraindications to TMS. Clinicians take special precautions on patients with
cardiac pacemakers or implanted medication pumps.
The most common side effect for TMS is headache and discomfort at the
site of stimulation. Headaches usually resolve within an hour; some patients pretreat with acetaminophen just before the TMS session. Site pain during
stimulation occurs under the TMS coil, but it seems to dissipate for most patients
after a few TMS sessions (Anderson et aI., 2009). For patient comfort, clinicians
may adjust the intensity of the first session and then increase to the target
intensity over the next few days. It is normal to have twitching of the eyebrow
during the pulse train, but mouth and jaw twitching during stimulation may
indicate poor coil placement.
The FDA approved TMS machine is a class II device for prescription use.
Each state regulates prescriptive authority, which includes nurse practitioners.
Physicians or clinicians with prescriptive authority dictate the dose of TMS, but
other clinicians usually administer the TMS treatment. The person administering
TMS is medically trained and able to manage a seizure. Previous seizures
related to TMS were short in duration and self limiting; however, TMS clinics
must be prepared to deal with this medical emergency and a clear written seizure
plan must be in place. The clinician monitors the patient at all times during the
TMS session.
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CONCLUSION:
The use of TMS as treatment for depression is growing exponentially.
Nurses have an opportunity to shape the future of this new technology, as they
are well suited to administer TMS and manage possible adverse events, such as
seizure. Currently, there are no standard TMS training protocols for nurses. As
the frontline providers of TMS, nurses need to establish TMS training certification
courses and other TMS related educational opportunities for nurses. Learning
how to administer TMS safely and effectively requires much more than reading a
manual; it requires hands on instruction and practice. Procedures that test the
TMS administrator's ability to determine the MT and treatment sites may increase
treatment delivery uniformity across TMS clinics, thus yielding more effective
treatments for patients.
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CONCLUSION
This dissertation document consists of three manuscripts; (1) a review of
literature, (2) methods and research findings, and (3) an introduction to TMS in
clinical settings. The information found in this document will help nurses as
premier providers of TMS establish TMS administration and training protocols.
The literature review shows that despite the relatively small evidence to support
the assertion that the OM method is similar to the EMG-assisted method for
determining motor threshold in clinical settings, many clinicians are using the
faster, less complicated OM method. The lack of a consensus on how to perform
the motor threshold procedure likely effects treatment outcomes.
This study showed that the mean differences between OM and EMG
methods were small, but it revealed the inconsistent nature of the MT procedure.
Both methods failed to identify the optimal treatment location in most cases.
The EMG or OM method along with the 5 cm rule may position the coil posterior
and medial to the intended location. Study results indicate the need for
developing other methods for determining TMS intensity and treatment location.
In this study, nurses with minimal TMS training were able to perform the
MT procedure with similar accuracy as experienced TMS administrators. This
study suggests that nurses can learn the MT procedure quickly and can be
effective TMS administrators. There is a need, therefore, for nurse directed TMS
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training and TMS administration certifications. The methods for recording coil
placement used in this study are excellent techniques for testing the accuracy of
TMS trainees. Holding all TMS administrators to high uniform standards ensures
consistency across TMS clinics and positive outcomes for depressed patients.
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APPENDIX - ALL COORDINATES FOR ALL SUBJECTS

Lear
Rear
TipNose
bridge Nose
Cz
AntCz
PostCz
LeftCz
RightCZ
a011aemt
a011aetx
a011 bvmt
a011 bvtx
a012avmt
a012avtx
a012bemt
a012betx
a021aemt
a021aetx
a021 bvmt
a021 bvtx
a022avmt
a022avtx
a022bemt
a022betx
a031aemt
a031aetx
a031bvmt
a032avtx
a032bemt
a031 bvtx
a032avmt
a032betx
a041avmt
a041avtx
a041bemt
a041 betx
a042aemt
a04aetx

x
153.576935
4.125
76.3125
78.375
84.166672
84.891304
86.5
129.833344
37.166668
137.446808
123.404259
118.723412
105.106384
126.808517
119.574471
136.595749
116.595749
124.347824
110.434784
128.695648
113.04348
130.434784
119.420288
120.86956
111.5942
136.773514
125.714279
132.421005
109.223557
132.787048
119.895241
118.193565
122.441467
124.077217
123.675552
126.597435
127.618065
119.199074
127.695915

y

125.8125
132.6875
13.0625
36.4375
156
108.333336
195.666672
150.333344
155
140.555557
80.361115
128.027786
69.666672
162.555573
80.361115
151.555573
79.75
131.772736
83.886787
146.641663
97.157677
153.541275
101.435791
157.220428
105.378632
128.039658
89.523804
132.057495
95.216995
128.973419
88.912842
137.673782
85.69445
150.499939
103.343468
153.624008
114.769661
154.812775
118.289612

z
111.100006
114.537506
100.787498
145.475006
246.933334
243.020294
233.600021
228.93335
233.600021
222.127655
209.787231
235.319153
216.595734
230.212769
214.468079
223.404251
216.595734
232.753632
225.217392
228.985504
229.565216
227.536224
227.82608
235.36232
234.782608
220.147324
213.015869
227.020386
230.20726
224.702881
218.335602
236.674744
214.611786
232.146378
224.371674
230.735962
225.476456
235.429749
226.292664
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a042bemt
a042betx
a051avmt
a051 avtx
a051 bemt
a051 betx
a052aemt
a052aetx
a052bvmt
a052bvtx
a061avmt
a061 avtx
a061bemt
a061 betx
a06saemt
a062aetx
a062bvmt
a062bvtx
a07avmt
a07avtx
a071bemt
a071 betx
a072aemt
a072aetx
a072bvmt
a072bvtx
a081aemt
a081aetx
a081 bvmt
a081 bvtx
a082avmt
a082avtx
a082bemt
a082betx
a091aemt
a091aetx
a091 bvmt
a091 bvtx
a092avmt
a092avtx
a092bemt
a092betx
a1 01 avmt
a1 01 avtx
a101bemt
a1 01 betx
a102aemt
a102aetx

122.111893
126.869881
108.748055
101.403557
106.456741
110.18222
108.20681
98.977432
115.555328
107.620575
114.457787
111.697586
117.805244
116.087593
108.05101
105.649498
113.391052
107.380135
121.682915
100.735146
121.502235
112.234978
104.025711
109.266899
110.477127
102.675125
120.070297
99.178596
112.361137
98.522621
107.803085
87.954872
112.804199
94.941711
113.944473
110.192474
112.539017
114.295662
117.67025
121.978355
122.123329
119.910522
136.902328
119.136627
114.213181
102.852135
120.832535
105.447067

161.567886
117.513626
137.892883
107.67569
140.660431
105.21286
130.880447
98.709496
129.505203
104.961853
144.168106
96.111969
173.372269
118.078789
173.908768
123.517525
158.917847
112.586823
142.6259
96.46637
141.583908
91.112785
155.128372
108.105812
148.985855
99.643814
154.05864
91.88765
153.813217
99.93557
153.684952
98.508911
144.804855
96.493774
161.958374
114.962219
175.345901
125.598816
170.073471
117.106804
173.714371
114.797112
154.096481
109.630676
138.728485
94.232338
144.34581
96.713196

233.010574
226.49733
241.355408
239.296051
242.85907
234.573273
240.531693
237.245773
236.995758
235.225357
239.552292
229.69014
233.280609
235.344238
237.34964
240.854141
238.930923
237.623093
235.010132
235.499466
234.354538
226.817017
242.274078
235.75119
240.627655
236.410706
234.919281
234.185074
239.348877
237.886337
240.988022
239.603149
239.174728
237.991531
237.647156
236.897568
234.788315
237.249435
233.620758
231.375244
230.220139
231.622513
221.638885
229.391617
238.496658
233.697647
234.387665
233.596054
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a102bvmt
a102bvtx
a111aemt
a111 aetx
a111 bvmt
a111 bvtx
a112avmt
a112avtx
a112bemt
a112betx
a121aemt
a121aetx
a121 bvmt
a121 bvtx
a122avmt
a122avtx
a122bemt
a122betx
a131avmt
a131 avtx
a131 bemt
a131 betx
a132aemy
a132aetx
a132bvmt
a132bvtx
a141avmt
a141avtx
a141 bemt
a141 betx
a142aemt
a142aetx
a142bvmt
a142bvtx
a151aemt
a151aetx
a151 bvmt
a151 bvtx
a152avmt
a152avtx
a152aemt
a152aetx

115.16375
108.488159
129.098312
129.2509
128.960846
133.671524
122.481224
115.957695
122.729965
118.943962
149.37056
140.31044
135.487091
133.839767
134.368729
135.143097
152.025192
136.474289
132.660599
121.504715
131.8423
121.347176
129.42186
124.457184
132.265411
117.392014
116.459541
111.20533
122.87059
116.171265
120.259796
114.005165
119.600876
114.831078
124.820961
113.711525
116.835358
105.399864
129.176086
108.9319
123.607719
111.990051

139.164017
101.04483
166.232651
117.296738
132.639893
102.515373
149.709137
105.100403
129.640732
90.898346
143.480438
114.582191
155.400986
111.02137
160.621475
110.980347
144.143982
115.496048
157.715942
115.46936
142.751755
96.880959
141.118729
109.427902
140.048492
104.4832
162.520538
118.288635
170.923813
125.76075
163.892227
121.4534
163.983643
117.890968
155.54924
112.778786
151.944794
108.824028
160.88942
105.732819
151.656311
107.507027

237.673645
233.143387
227.850754
225.072708
228.212708
213.224213
234.096786
230.876144
232.789413
221.654785
205.025253
208.522263
223.533554
216.021927
222.911575
214.604919
200.755783
214.120529
224.507507
231.413513
227.567749
222.01622
228.066864
226.450348
226.143051
229.312225
235.523727
237.181046
230.742172
236.287369
233.973831
236.629593
234.306564
236.200256
232.592499
234.843079
237.558578
238.066711
228.17627
235.958542
233.960999
234.835953
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